Melanoma research program
Ended Awarded Last action
- Contract number
- HT942525F0218
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $203,408
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 100% obligated
- $203,408.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $10,760 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $80,957 | |
| Original award | $111,691 |
About this award
Leidos, Inc., through its Leidos Services Operating Segment division, was awarded a delivery order valued at $203,408.38 under a cost-plus-fixed-fee contract for the Melanoma Research Program, funded by the Defense Health Agency. The work will be performed in Reston, Virginia, with an ultimate completion date of June 30, 2026. This delivery order was issued without a set-aside designation, reflecting Leidos' status as an established prime contractor. The award supports the Defense Health Agency's congressionally directed medical research initiatives, which fund critical cancer research programs across multiple tumor types, including melanoma, as part of the Department of Defense's broader commitment to advancing medical research for warfighter health and readiness.
As a major federal contractor with extensive experience supporting medical research programs, Leidos brings substantial expertise in delivering administrative and technical services for defense health initiatives. The company maintains a $105.5 million single-award indefinite delivery contract with the Naval Health Research Center through September 2030 for non-personal research and development support services, positioning it as an established provider of research infrastructure and support services to Defense Health Agency missions. This melanoma research delivery order represents continued engagement with the Defense Health Agency's portfolio of oncology research programs designed to advance understanding and treatment of skin cancer among military personnel and the broader population.
Quick answers
Who was awarded contract HT942525F0218?
HT942525F0218 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 1, 2025.
How much is contract HT942525F0218 worth?
The government has obligated $203,408 on HT942525F0218.
Is contract HT942525F0218 an order under another contract?
Yes. HT942525F0218 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942525F0218 competed?
The extent of competition for HT942525F0218 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award